26 April 2022
: Case report
A Case of Synthetic Cannabinoid (K2)-Induced Posterior Reversible Encephalopathy Syndrome (PRES)
Unusual clinical course, Challenging differential diagnosis
Haider Ghazanfar1ABCDEF*, Aruna Muthumanickam
DOI: 10.12659/AJCR.936209
Am J Case Rep 2022; 23:e936209